Events and training
line
PVAM care bundles: how we can measure their economic benefit
line
Facebook LinkedIn Emailline
Contact Us

PVAM care bundles: how we can measure their economic benefit

A common procedure with high risk

Peripheral intravenous catheter (PIVC) placement is the most common invasive procedure carried out at healthcare facilities.1 Intravenous (IV) therapy with PIVCs is associated with the risk of infection, complications, extended length of stay, morbidity and the resulting additional costs.1,2  

What PVAM care bundles can do for patients

To offset these risks and improve clinical outcomes, the peripheral vascular access management (PVAM) care bundle strategy has been developed as an integrated approach to delivering a high standard of care. With this strategy, it is possible to reduce vascular access complications by implementing and adhering to effective practice in device selection, disinfection, maintenance of patency and connection to the line.2  

There are multiple goals to PVAM:  

  • Minimise insertion attempts2  
  • Optimise catheter patency3 
  • Reduce the risk of IV complications2 
  • Prevent exposure to bloodborne pathogens from needlestick injuries2 
  • Lower the risk of catheter-related bloodstream infections2 

In a study by Schettini et al, a health economic model estimated that a PVAM approach would save 1.33 minutes and €2.11 per procedure, leading to a savings of 3.51% per year for the implementation of 156,624 PIVCs in an Italian hospital.2 According to the CLEAN-3 study, when a PVAM care bundle was compared to standard practice, Maunoury et al estimated the mean savings per patient at €42.4 

More on this topic: Peripheral venous catheters: Cost impact of PVC care bundles

Health economics to assess PVAM care bundles

BD can provide business cases and reports based on modelling that we can run internally with your healthcare facility’s data to understand the overall economic impact a care bundle could have on patients, staff and costs when applied to your institution.  

BD has created a health economic model that estimates the number and cost of complications, the cost of consumables and nurse time spent managing catheters for a cohort of patients, where the risk of complications could be mitigated using PVAM care bundle strategies based on published evidence.  

More on this topic: CVAM care bundles: how we can measure their economic benefit

PVAM impact we can measure

Using a PVAM health economics model to estimate the clinical and economic impact of the PVAM care bundle strategy can the decision-making process to implement best practice clinical procedures while reducing overall costs. 

References

  1. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189-203. doi:10.1097/NAN.0000000000000100
  2. Schettini F, Ferrario L, Foglia E, et al. The implementation of a standardized optimal procedure for peripheral venous catheters’ management: Results from a multi-dimensional assessment. PLoS One. 2022;17(1):e0263227. doi:10.1371/journal.pone.0263227
  3. Guenezan J, Marjanovic N, Drugeon B, et al. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter  infection and failure (CLEAN 3 study): an investigator-initiated, open-label,  single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis. 2021;21(7):1038-1048. doi:10.1016/S1473-3099(20)30738-6
  4. Maunoury F, Drugeon B, Boisson M, et al. Cost-effectiveness analysis of bundled innovative devices versus standard approach in the prevention of unscheduled peripheral venous catheters removal due  to complications in France. PLoS One. 2022;17(6):e0269750. doi:10.1371/journal.pone.0269750

This list of references to third party peer reviewed material and the sites they are hosted on are provided for your reference and convenience only, and do not imply any review or endorsement of the material or any association with their operators.  The Third Party References (and the Web sites to which they link) may contain information that is inaccurate, incomplete, or outdated. Your access and use of the Third Party Sites (and any Web sites to which they link) is solely at your own risk. 

BD-95590